· Original article
Cloud switching keeps AWS and Microsoft under UK scrutiny
Cloud switching barriers remain under UK scrutiny as the CMA seeks further changes from AWS and Microsoft, with another update planned for spring 2027.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 3,998 · Page 244 / 334
· Original article
Cloud switching barriers remain under UK scrutiny as the CMA seeks further changes from AWS and Microsoft, with another update planned for spring 2027.
· Original article
Tonbo Imaging IPO plans accompany a push into railway safety and vehicle sensors, while the ₹852-crore offer would provide no fresh company capital.
· Original article
The Copart acquisition of ACV Auctions closed on October 16, 2026, at $10.50 per share in cash, with about $1.8 billion paid to acquire control.
· Original article
Nike India campus plans form part of a global overhaul, with regional changes expected in fiscal 2028 and workforce decisions beginning in 2027.
· Original article
Omeros stock fell 12.03% intraday on October 16, 2026, after an EMA committee reaffirmed its negative opinion on narsoplimab following re-examination.
· Original article
Prudential Japan suspension reduced estimated Q3 operating income by $140 million, with new-business restrictions extending through January 2027.
· Original article
Nucor shares gained 3.1% on October 16, 2026, as U.S. industrial output rose 0.7% in September, while major Wall Street indexes closed mixed.
· Original article
Nucor earnings guidance points to stronger third-quarter profit as steel prices rise, though higher costs and weaker raw materials limit the benefit.
· Original article
IDEXX stock rose to $557.90 in an October 16, 2026 snapshot, while its earlier annual results provide context on recurring diagnostics growth.
· Original article
Rhythm coverage begins with an Outperform rating at William Blair, while the firm's later announcement confirms its broader biotech research expansion.
· Original article
KVB credit growth guidance targets 18–20% in FY27, led by retail, agriculture and small businesses, with corporate lending kept near a 20% ceiling.
· Original article
IDEAYA coverage began with an Outperform rating in an October 16 update. William Blair later confirmed the company joined its expanded biotech research.
Charts and market data by TradingView. Availability and delays vary by exchange.